Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TATA-box binding protein associated factor 12 (TAF12) is a highly conserved subunit of the transcription factor IID (TFIID) complex, which is critical for the initiation of transcription by RNA polymerase II[2][3]. TAF12 interacts with the TATA-binding protein (TBP) and other TAFs, notably forming a histone-like heterodimer with TAF4[1][3]. Through these interactions, TAF12 facilitates assembly of the transcription pre-initiation complex and contributes to regulation of gene expression across eukaryotes[2][3]. TAF12 may also participate in additional regulatory complexes such as SAGA, and its precise requirement and function can vary in different cell types and organisms[1]. Disruption of TAF12 function can impair cell growth and viability, reflecting its central role in gene regulation. There are reported associations with certain cancers, but TAF12 is not currently a direct drug target and there are no approved therapeutic strategies targeting this factor[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA-box binding protein associated factor 12 (TAF12).